Literature DB >> 2176931

Gonadal toxicity following cancer therapy in adults: significance, diagnosis, prevention and treatment.

E D Kreuser1, W D Hetzel, D O Billia, E Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2176931     DOI： 10.1016/0305-7372(90)90043-f

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  4 in total

1.  Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.

Authors:  Guiping Song; Hui Gao; Zhixiang Yuan
Journal:  Med Oncol       Date:  2013-08-01       Impact factor: 3.064

2.  Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.

Authors:  Sibylle Loibl; Nicos Fersis; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2011-12-20       Impact factor: 2.860

3.  Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis.

Authors:  Zhen-Yu Li; Ying-Li Dong; Xiao-Zhong Cao; Sha-Sha Ren; Zhen Zhang
Journal:  Menopause       Date:  2022-08-02       Impact factor: 3.310

4.  Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.

Authors:  Xiaoyan Li; Xiang Kang; Qingchun Deng; Jing Cai; Zehua Wang
Journal:  Reprod Biol Endocrinol       Date:  2013-03-01       Impact factor: 5.211
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.